GST exemption on COVID-19 medicines reduces SGST rates for listed antiviral and biologic treatments listed. Exempts specified medicinal products used for COVID-19 from a portion of State GST by prescribing reduced rates for listed Chapter 30 tariff items at either Nil or 2.5 percent. The notification lists Tocilizumab and Amphotericin B at Nil rate and several antiviral, biologic and adjunct therapies at 2.5 percent. The exemption is effective from 1 October 2021 through 31 December 2021 as a time limited State tax relief.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST exemption on COVID-19 medicines reduces SGST rates for listed antiviral and biologic treatments listed.
Exempts specified medicinal products used for COVID-19 from a portion of State GST by prescribing reduced rates for listed Chapter 30 tariff items at either Nil or 2.5 percent. The notification lists Tocilizumab and Amphotericin B at Nil rate and several antiviral, biologic and adjunct therapies at 2.5 percent. The exemption is effective from 1 October 2021 through 31 December 2021 as a time limited State tax relief.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
